Blog

AI has moved from hype to execution in Life Sciences and Healthcare. Investors are backing AI driven platforms that make diagnostics data more actionable for BioPharma, fueling precision medicine and premium valuations. The companies that will win are those pairing great science with Commercial leaders who know how to execute.

Life Sciences companies used to wait until commercialization to build out Sales and Marketing leadership. Not anymore. Today, CEOs and Investors are hiring commercial leaders earlier — often pre-revenue — to shape the strategy and drive valuation. Here’s why that shift is accelerating.

The Life Sciences market has shifted — and so has the commercial leadership playbook. In this environment of economic uncertainty and longer sales cycles, great CCOs and VPs of Sales are adapting fast. Here's what they’re doing differently — and why it matters to CEOs and Investors.